Author's reply ED1TOR,-We cannot check on the proportions of overt haematemesis to melaena without going back to original records. We think it unlikely that Dr Fryer's explanation will account for the trends observed. If doctors had warned patients to watch for the ill effects of aspirin on the upper gut then we would not have expected to see the steadily increasing risk with aspirin dose. Also, very low dose aspirin was believed to be safe and therefore precautions are unnecessary, so warnings by doctors about the possible hazards of low dose aspirin will have been unlikely. It is a pity, however, given the large number of time related significant changes in treatment found for both intervention and control groups, that the study did not have a control group of children from practices where no intervention was made. This would better confirm the conclusion that intervention increased the likelihood of diagnosis of childhood asthma and planned review but did not make major changes in treatment. From the evidence presented, time related changes for both groups (decrease in use of oral bronchodilators, theophyllines, antibiotics, and cough linctus; increase in inhaled and oral steroids) suggest that practice prescribing was also influenced for children in the control group. In support of the conclusion that practices were changing habits at this time, it may be of interest that over much the same period, in the neighbouring Grampian and Highland regions, a similar decrease in use of oral bronchodilators and increase in use of inhaled steroids was found for adults.2
None the less, we all need to remember that studies which introduce management interventions for (randomly) selected patients within a practice are not as "clean" as clinical trials of procedures or drug treatment. The same doctors and nurses whose behaviour is being changed in relation to the intervention group are also managing the control group. Without a completely independent control group it is difficult to interpret findings if few differences are found between intervention and control. Mineralocorticoid effects of high dose hydrocortisone EDrrOR,-In their recent Lesson of the Week B H Ramsahoye and colleagues highlight the mineralocorticoid effect of high dose hydrocortisone as the principal factor that resulted in the fall in serum potassium concentrations (2-9 to 2-0 mmolll) in their patient.' The episodes of ventricular fibrillation which followed were attributed to this fall in serum potassium concentration. Whereas intravenous hydrocortisone certainly contributed to the reduction in serum concentration of potassium, we suggest that other factors responsible for this change were a combination of inadequate supplementation, inappropriate cessation of potassium supplementation (at a serum concentration of 2-9 mmol/l), and, perhaps most importantly, significant continued urinary losses of potassium in the face of magnesium depletion.
The authors suggest that a reduction in serum potassium concentration of 1 mmol/l represents depletion in total body potassium of 100-200 mmol. Other workers would put the figure at twice this, with serum potassium concentrations of 3 0 mmol/l and 2-0 mmolll representing total body potassium deficits of 350 Interventions in OXCHECK study waste resources EDrTOR,-The OXCHECK study showed significant reductions in total cholesterol concentration (3-1%) and blood pressure (2-5/1-5 mm Hg) with health checks over three years.' The reductions in cholesterol concentration are in line with responses shown in previous controlled trials.2 The authors seem in some doubt about whether these effects are large enough to justify the cost of the health checks. This may be clearer when the projected benefits are considered in absolute rather than relative terms.
When the Framingham parametric model is used to estimate risk3 with the mean blood pressure and mean total cholesterol concentration in the OXCHECK study, assuming a mean age of 50 and with weighting for the proportion of smokers, the risk of coronary death in the control group is about 0 075% a year in non-diabetic men without electrocardiographic evidence of left ventricular hypertrophy. In the intervention group the estimated rate of coronary death is lowered to 0-066% a year. This is a reduction in risk of 12% in relative terms, but in absolute terms 11000 men would need to have health checks for one coronary death to be prevented each year. For women the reduction in relative risk seems even more impressive, at 25%, but over 80 000 women would need health checks for one coronary death to be prevented each year. If the study population had only a single initial health check lasting one hour and no follow up visits, seven practice nurses would be employed full time for one year to prevent one coronary death in men, and an additional 41 would need to be employed to prevent one death on women.
It is important to advise opportunistically on measures such as stopping smoking and increasing exercise, but whether the time and resources needed to implement these measures systematically, as tested in the OXCHECK study, can be justified is doubtful. It seems more appropriate to concentrate resources on lowering cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors after myocardial infarction4 and in patients with other forms of coronary heart disease.5 
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